A detailed history of Emprise Bank transactions in Abb Vie Inc. stock. As of the latest transaction made, Emprise Bank holds 1,634 shares of ABBV stock, worth $278,874. This represents 0.16% of its overall portfolio holdings.

Number of Shares
1,634
Previous 2,132 23.36%
Holding current value
$278,874
Previous $421 Million 31.03%
% of portfolio
0.16%
Previous 0.24%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 13, 2025

SELL
$164.99 - $203.87 $82,165 - $101,527
-498 Reduced 23.36%
1,634 $290 Million
Q3 2024

Oct 01, 2024

SELL
$163.84 - $199.33 $155,811 - $189,562
-951 Reduced 30.85%
2,132 $421 Million
Q2 2024

Jul 29, 2024

SELL
$154.79 - $180.76 $165,934 - $193,774
-1,072 Reduced 25.8%
3,083 $529 Million
Q1 2024

Apr 08, 2024

BUY
$159.82 - $182.1 $664,052 - $756,625
4,155 New
4,155 $757 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $302B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Emprise Bank Portfolio

Follow Emprise Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Emprise Bank, based on Form 13F filings with the SEC.

News

Stay updated on Emprise Bank with notifications on news.